Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dupilumab may help regrow hair in people with severe alopecia.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Dupilumab users have a higher risk of developing alopecia areata.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The drug combination was safe and showed promise in treating advanced tumors.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Dupilumab can both heal and cause hair loss.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Dutasteride may help reduce brain inflammation and improve cognition.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Anti-CD19 therapy may help treat SLE and NMOSD.